You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endothelin

Showing 1 - 25 of 694
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Hypertension, Adolescent Obesity Trial in Surabaya

Not yet recruiting
  • Obesity
  • +2 more
    • Surabaya, Jawa Timur, Indonesia
      RS Bhayangkara Surabaya
    Jul 16, 2023

    Hypertension Trial in Augusta (Bosentan, Placebo)

    Active, not recruiting
    • Hypertension
    • Augusta, Georgia
      Georgia Regents University
    Jul 18, 2022

    Hypertension Trial in Augusta (Candesartan, Placebo)

    Active, not recruiting
    • Hypertension
    • Augusta, Georgia
      Georgia Prevention Institute/ Laboratory of Integrative and Exer
    Jul 18, 2022

    Type 1 Diabetes Trial in Augusta (Resveratrol, Placebo)

    Recruiting
    • Type 1 Diabetes
    • Augusta, Georgia
      Augusta University/Georgia Prevention Institute/ Laboratory of I
    Jul 18, 2022

    Cardiac Allograft Vasculopathy Trial in Los Angeles (Macitentan)

    Recruiting
    • Cardiac Allograft Vasculopathy
    • Los Angeles, California
      Ronald Regan UCLA Medical Center
    May 9, 2022

    Preeclampsia, Microvascular Function Trial (Acetylcholine, Endothelin-1)

    Not yet recruiting
    • Preeclampsia
    • Microvascular Function
    • (no location specified)
    Dec 15, 2022

    ive Alzheimer's Medicines - PDE5 Inhibitors vs Endothelin

    Active, not recruiting
    • Pulmonary Arterial Hypertension
    • PDE5 inhibitor
    • Endothelin Receptor Antagonists
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Nov 15, 2021

    Heart Failure Trial in Salt Lake City (BQ-123)

    Completed
    Has Results
    • Heart Failure
    • Salt Lake City, Utah
      VA Salt Lake City Health Care System, Salt Lake City, UT
    Dec 17, 2021

    Cardiovascular Diseases, Cardiovascular Risk Factor, Vasoconstriction Trial in Arlington (BQ-788, BQ-123, L-Arginine)

    Recruiting
    • Cardiovascular Diseases
    • +2 more
    • Arlington, Texas
      Science and Engineering Research and Innovation Building
    Feb 7, 2022

    Hypertension, Pure Autonomic Failure, Multiple System Atrophy Trial in Nashville (BQ123, Bq123, Saline)

    Withdrawn
    • Hypertension
    • +2 more
    • Nashville, Tennessee
      Vanderbilt University
    Sep 27, 2021

    Anti-Angiotensin-Receptor 1-, Anti-Endothelin-Receptor

    Completed
    • Cardiac Failure
      • Wetzikon, Switzerland
        GZO Regional Health Center
      Jul 13, 2021

      Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

      Enrolling by invitation
      • Chronic Kidney Diseases
      • Aurora, Colorado
      • +5 more
      Oct 18, 2022

      Type 1 Diabetes With Diabetic Nephropathy Trial in Worldwide (Sotagliflozin, Ambrisentan, Ambrisentan and Sotagliflozin)

      Not yet recruiting
      • Type 1 Diabetes Mellitus With Diabetic Nephropathy
      • Aurora, Colorado
      • +6 more
      Oct 2, 2023

      Premature Infants With Bronchopulmonary Dysplasia

      Completed
      • Bronchopulmonary Dysplasia (BPD)
      • Hypertension, Pulmonary
        • Mountain View, California
        • +1 more
        Sep 23, 2021

        After Changing Medication From Nonselective to Selective

        Not yet recruiting
        • Eisenmenger Complex
          • (no location specified)
          Jan 26, 2021

          COVID-19, MIS-C Associated With COVID-19 Trial in Haifa (Cardiopulmonary exercise test (CPET), Peripheral Arterial Tonography

          Recruiting
          • COVID-19
          • MIS-C Associated With COVID-19
          • Cardiopulmonary exercise test (CPET)
          • +2 more
          • Haifa, Israel
            Rambam Medical Center
          Jan 23, 2022

          Vasculitis Trial in Edinburgh (BQ123, BQ123/788, Placebo)

          Completed
          • Vasculitis
          • Edinburgh, Midlothian, United Kingdom
          • +1 more
          Nov 30, 2020

          Acute Myeloid Leukemia, Adult, Cardiotoxicity, Endothelial Dysfunction Trial in Samara (History taking, Anthropometry, Complete

          Recruiting
          • Acute Myeloid Leukemia, Adult
          • +2 more
          • History taking
          • +14 more
          • Samara, Samara Region, Russian Federation
            Clinics of the Samara Medical University
          Jan 26, 2023

          ET1 Concentration, Metabolic Pathway Activation, and Pulmonary

          Recruiting
          • Single-ventricle
          • +4 more
          • Research Blood Sampling
          • Denver, Colorado
            Children's Hospital Colorado
          Aug 16, 2021

          Resistant Hypertension Trial (Bosentan, Placebo)

          Not yet recruiting
          • Resistant Hypertension
          • (no location specified)
          May 13, 2020

          Kidney Failure, Acute Trial in Haifa (Ambrisentan 10 MG)

          Unknown status
          • Kidney Failure, Acute
          • Ambrisentan 10 MG
          • Haifa, Israel
          • +1 more
          Jun 24, 2020

          Raynaud Disease, Systemic Sclerosis, Digital Ulcer Trial in Seoul (Calcium Channel Blockers, Phosphodiesterase Inhibitors,

          Terminated
          • Raynaud Disease
          • +2 more
          • Calcium Channel Blockers
          • +4 more
          • Seoul, Korea, Republic of
            Seoul National University Hospital
          Nov 8, 2020

          Sickle Cell Anemia Trial in Augusta (Ambrisentan, Placebo)

          Completed
          • Sickle Cell Anemia
          • Augusta, Georgia
            Augusta University
          Apr 1, 2020

          Migraine With Aura Trial in Glostrup (Endothelin-1, Placebo)

          Unknown status
          • Migraine With Aura
          • Glostrup, Denmark
            Danish Headache Center
          Dec 10, 2019

          ANCA Associated Vasculitis, Cardiovascular Diseases, Kidney Diseases Trial in Edinburgh (Sparsentan)

          Recruiting
          • ANCA Associated Vasculitis
          • +2 more
          • Edinburgh, United Kingdom
            Centre for Cardiovascular Science, Queen's Medical Research Inst
          Jan 26, 2023